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This protocol allows repeated whole-cell patch-clamp recordings from individual rodent CA1 
hippocampal neurons, followed by immunohistological labelling of the axon initial segment. This 
overcomes the need to maintain whole-cell recordings over the timescales required for 
homeostatic modification to cellular excitability, allowing for correlative analysis of the structure 
and function of neurons. Moreover, this protocol allows for paired analysis of physiological 
properties assessed before and after pharmacological treatment, thus providing increased 
statistical power, despite the relatively low-throughput nature of the recordings. 
 
 
For complete details on the use and execution of this protocol, please refer to Booker et 











• Protocol allows repeated whole-cell patch-clamp recording in ex vivo hippocampal neurons 
• Produces within neuron controls, increasing statistical power through paired analysis 
• Allows for axon initial segment labelling following whole-cell patch-clamp recordings  







Before You Begin 
 
Acute hippocampal brain slice preparation: 
 
Timing: 30 minutes 
 
Full protocols for the preparation of acute brain slices in our research group have been 
previously described (Booker et al., 2014, Booker et al., 2017, Booker et al., 2020a, Booker, 
2020b). This protocol is not in specific chronological order, but rather with respect to each 
experimental aspect, in their respective order. It is more efficient to perform a number of days 
of electrophysiological recording, followed by subsequent batch processing of tissue and 
images. Briefly:  
 
1. Prepare holding chamber: 
a. Obtain plastic inserts to form 2 compartments in the chamber, one for holding 
slices and one to place carbogen bubbler: 
i. A cylindrical plastic insert of 2.5 cm diameter and 2 cm height can be 
obtained by cutting a 50 mL syringe.  
ii. From a 20 mL syringe, remove the plunger and the cut off top portion of 
the syringe body. Cut off the syringe tip and make small holes in the 
bottom of the syringe (Figure 1B).  
 
Note: A heated scalpel blade can be used to more easily cut through the plastic. 
 
b. Build holding compartment by stretching mesh over the smaller cylinder and 
applying superglue (Figure 1C).  
c. Once superglue has dried, cut excess mesh to match the diameter of the plastic 
insert (Figure 1D). 
d. Position the 2 plastic inserts inside the beaker as shown in Figure 1E-F. 
 
 
Note: All materials required to assemble a holding chamber can be found in Figure 1A. For this 
chamber design we have used a 150 mL beaker. Inserts can be adapted to assemble chambers 
of different sizes if required. 
 
 
2. Prepare high-sucrose artificial cerebrospinal fluid (ACSF) for slicing:  
a. Place ~200 mL sucrose-ACSF into a glass flask and put into a freezer at -20°C 
for ~30 minutes prior to preparation of acute slices. This will allow partial freezing 
of sucrose-ACSF to form a slushy consistency.   
b. Fill a submerged slice holding chamber with sucrose-ACSF in a water bath at 
35°C and aspirate with Carbogen (95%O2 / 5%CO2).  
3. Prepare the workspace: 
a. Add crushed ice to slicing chamber (Figure 2A). 
b. Layout tools used for brain dissection (Figure 2B). 
c. Agitate slushed sucrose-ACSF to ensure no large lumps of ice. Place flask of 
sucrose ACSF on ice and then aspirate with carbogen for at least 5-10 minutes 






d. Once satisfactorily carbogenated, transfer a small volume (~50 mL) of sucrose-
ACSF to a small glass beaker.   
 
Note: All tools and equipment required for removal of the brain and preparation for slicing can 
be found in Figure 2B. 
 
Whole-cell patch clamp recordings: prepare solutions 
 
Timing: 30-45 minutes 
 
4. Prepare recording ACSF. 
a. Place recording ACSF on water bath set to 40°C on the recording set up and 
bubble with carbogen. 
 
5. Prepare intracellular solution. 
 
Note: Intracellular solution can be prepared and stored in small aliquots (~1 mL) at -20°C for 
4-8 weeks prior to use. 
 
a. On the day of recording, add Alexafluor hydrazide 568 (final concentration 100 
µM) to aliquot of intracellular solution. 
 
Note: Other fluorescent dyes with different wavelengths can be used as appropriate to the 
optical pathway installed on the microscope being used for recording.  
 






For whole-cell patch clamp recordings: prepare equipment 
 
Timing: 10 mins 
 
6.  Prepare glass electrodes: 
a. Pull glass electrodes with tip resistance of 3-4 MΩ 
 
7. Start-up equipment: 
a. Switch on all equipment necessary for whole-cell patch-clamp recording:   
i. Amplifier, digitizer, PC 
ii. Digital camera, Infrared transmission and epifluorescent light sources. 
iii. Micromanipulators and microscope controllers 
iv. In-line heater and water bath 
 
Note: The specific equipment used for this protocol and our previous study is listed in the key 
resources table, however suitable alternatives can be used according to the experimental set 







b. Start flow of pre-warmed and carbogenated recording-ACSF and switch on in-
line heater. Set temperature of in-line heater to maintain a temperature of 
30 ± 1°C in the recording chamber. 
 
8.  Prepare holding chambers with control (15 mM NaCl) and treatment (15 mM KCl) 
ACSF.  
a. Measure required ACSF to fill holding chamber (typically 100-200 mL). 
b. Prepare sufficient ACSF with added NaCl or KCl. by adding the respective salt 
from 1 M stock solution. Add solution to separate, labelled holding chambers. 
c. Keep holding chambers bubbling with carbogen in a water bath at 35°C. 
 
Note: The specific treatment should be kept blind to the researcher performing recordings and 
AIS labelling and imaging. This can be achieved by labelling solutions A and B, and the key to 
the treatment kept blind until all analysis is completed.  
 
Prepare histological solutions: 
 
Timing: 1 h 
9. Prepare 0.4 M Phosphate Buffer (PB) stock solution (see Materials and Equipment). 
 
Note: stock solution can be prepared prior to experimental day and kept at 20 ± 2 °C (room 
temperature) for up to 1 month. 
 
10. Prepare 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB) for tissue fixation. 
 
Note: PFA can be made prior to experimental day, and stored in aliquots of 10-20 mL for 2-3 
months at -20°C. 
 
CRITICAL: PFA in its powdered form is highly toxic when inhaled. All PFA should be weighed 
and handled in a fume-hood or in a lab where appropriate personal protective equipment is in 
use by all lab members. 
 
11. Prepare phosphate buffered saline (PBS; 0.1 M PB with 0.9% NaCl) - from tablets 






Key Resources Table 
 
Key resources table 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Mouse monoclonal anti-AnkyrinG       (1µg/mL, 1:1000) NeuroMAB N106/36 
Rabbit polyclonal anti-AnkyrinG           (0.4 µg/mL, 1:500) Santa Cruz sc-28561 
Rabbit polyclonal anti-NeuN               (1µg/mL, 1:1000) Millipore EMD ABN78 
Mouse monoclonal anti-NeuN            (1µg/mL, 1:1000) Millipore EMD MAB377 
Alexa 488 goat anti-mouse                 (4 µg/mL, 1:500) Thermo Fisher Scientific A-11001 
Alexa 568 goat anti-mouse                 (4 µg/mL, 1:500) Thermo Fisher Scientific A-11004 
Alexa 568 goat anti-rabbit                   (4 µg/mL, 1:500) Thermo Fisher Scientific A-11011  
Alexa 633 goat anti-rabbit                   (4 µg/mL, 1:500) Thermo Fisher Scientific A-21071 
Steptavidin-Alexafluor 568 conjugate (4 µg/mL, 1:500) Thermo Fisher Scientific S11226 
Chemicals, Peptides, and Recombinant Proteins 
Isofane (100% Isofluorane) Henry Schein 988-3245 
K-gluconate Sigma-Aldrich P1847 
HEPES Sigma-Aldrich H3375 
Na2ATP Sigma-Aldrich A2383 
Na2Phosphocreatine Sigma-Aldrich P7936 
EGTA Sigma-Aldrich E3889 
Na2GTP Sigma-Aldrich G8877 
Biocytin Sigma-Aldrich B4261 
MgCl2 (1M stock) Honeywell - Fluka 63020 
Ca2Cl2 (1M stock) Honeywell - Fluka 21114 
Alexafluor 568 Hydrazide Thermo Fisher Scientific A10437 
PBS tablets Sigma-Aldrich P4417 
Triton-X 100 Sigma-Aldrich X100 
Sodium azide Sigma-Aldrich S2002 
Normal goat serum Vector Labs S-1000-20 
Experimental Models: Organisms/Strains 
Mouse: C57/Bl6J (P28 -35 males) Jackson Labs 000664 
Rat: Long-Evans Hooded (Crl:LE, P28 -35 males) Charles River 006 
Software and Algorithms 






























Stimfit (Guzman et al., 2014) https://github.
com/neurodr
oid/stimfit 
ImageJ (Schneider et al., 2012) https://imagej
.net/Fiji/Down
loads 
Imaris  Oxford Instruments Imaris for 
Neuroscientis
ts package 




Other   
Vibratome Leica VT1200S 
Horizontal pipette puller Sutter Instruments P-97 
Capillary glass (1.5/0.75 mm outer/inner diameter) Warner instruments 
GC150F-7.5 
 
Headstage amplifier Molecular Devices CV-7B 
Amplifier Molecular Devices 
Multiclamp 
700B 
Digitizer Molecular Devices Digidata 1440 
Micromanipulators Luigs and Neumann SM7 
Camera Hamamatsu Orca 2 
Microscope Olympus BX61WI 
Epifluorescent light source Prior Scientific Lumen200 
Sharp dissection scissors Fine Science Tools 14501-14 
Fine dissection scissors Fine Science Tools 14106-09 






Vectashield mounting medium Vector Labs H-1400 
Microscope slides Thermo Scientific 12362098 
 
 
Materials and Equipment  
 
Solution compositions for slice preparation and recording: 
Sucrose ACSF 
 
Reagent Concentration (mM) Mass/Volume 
NaCl 86 5.03 g 
KCL 2.5 0.19 g 
D-glucose 25 4.51 g 
Sucrose 75 25.67 g 
NaH2PO4 1.2 0.19 g 
NaHCO3 25 2.10 g 
CaCl2 0.5 0.5 mL 
MgCl2 7 7 mL 
ddH2O - Adjust to 1 L total volume 
 
Recording ACSF 
Reagent Concentration (mM) Mass/Volume 
NaCl 124 14.49 g 
KCL 2.5 0.37 g 
D-glucose 20 7.21g 
NaH2PO4 1.2 0.37 g 
NaHCO3 25 4.21g 
Ca2Cl2 (1M stock) 2 4 mL 
MgCl2 (1M stock) 1 2 mL 
ddH2O - Adjust to 2 L total volume 
Store Sucrose ACSF at 4°C for up to 5 days. Prepare fresh recording ACSF on the day of 
recording. Following bubbling with carbogen, the pH of ACSF should be 7.3 – 7.4. Osmolarity 
should be 310 – 320 mOsm.L-1 for recording ACSF and 320-330 mOsm.L-1 for Sucrose 
ACSF.  
Potassium-gluconate based intracellular solution composition (pH 7.3, 290-300 
mOsm.L-1): 
Reagent Concentration (mM) Mass/Volume 
K-gluconate 142 1.6628 g 
HEPES 10 0.1191 g 
KCl 4 0.0149 g 
MgCl2 (1M stock) 2 100 µL  
Na2ATP 2 0.0551 g 
Na2Phosphocreatine 1 0.0128 g 






Na2GTP 0.3 0.0078 g 
Biocytin 2.7 0.0500 g 
ddH2O - Adjust to 50 mL total volume. 
 
Intracellular solution can be prepared and stored in small aliquots (~1 mL) at -20°C for 4-8 
weeks prior to use. 
 
Alternative: Internal solution can be made without biocytin, and biocytin can be added to each 
individual aliquot of internal solution on the day before starting recordings.  
 
 
Phosphate buffer 0.4 M stock solution composition (pH 7.4): 
Reagent Concentration (mM) Weight (g) 
NaH2PO4 300 6.2 
Na2HPO4 100 22 
ddH2O - Adjust final volume to 500 mL 
 
Stock solution can be kept at 20 ± 2°C for up to a month. 
 
Phosphate buffered saline (PBS), pH 7.4 
Prepare from Sigma-Aldrich PBS tablets. Add 5 tablets to 1 L of ddH2O. Prepare PBS on the 
day of use and keep at 4°C for up to 2 weeks. 
 
Alternative: prepare PBS from 0.4 M PB stock solution: 0.1 M PB with 0.9% NaCl. 
 
 
Step-by-Step Method Details 
 
Acute slice preparation 
 
Timing: 20 min 
 
This step describes the preparation of acute hippocampal slices to be used for 
electrophysiological recordings and subsequent histological processing. 
 
CRITICAL: Prior to commencement of any rodent work, ensure that all legal aspects pertaining 
to the use of animals in scientific research have been obtained from both institutional and 
regional organizations.  
 
Note: All work outlined in this protocol has been performed in line with UK Home Office 
guidelines (ASPA 2013) and The University of Edinburgh Ethical Board. 
 
1. Dissect brain:  
a. Anaesthetize mouse or rat by placing in an anesthetic chamber containing suitable 
concentration of a volatile anesthetic (e.g. isofluorane).  
Note: We use ~1 mL of isofluorane in a 5 L anesthetic chamber, however the exact method 






b. Confirm deep anesthesia – reduction of breathing and absence of reflexes. 
c. Decapitate rodent using a pair of sharp scissors or guillotine.  
d. Rapidly remove skull, using a pair of fine scissors. 
e. Using curved, blunt-tip forceps to remove the skull from between bregma and the 
zygomatic arch.  
f. Using a small spatula, gently separate the brain from the skull, taking care to sever the 
cranial nerves. Roll brain into small beaker of sucrose-ASCF (Before You Begin Step 2c.) 
 
Note: All tools and equipment required for removal of the brain and preparation for slicing can 
be found in Figure 2. 
 
CRITICAL: The dissection of the brain following decapitation should ideally take <30 seconds 
to ensure high quality brain slices.   
 
2. Prepare horizontal brain slices of the hippocampus: 
a. Transfer brain from small beaker to glass petri dish, lined with disc of filter paper.  
b. Using a scalpel, remove cerebellum and frontal third of brain.  
c. Apply a small amount of cyanoacrylate glue (Superglue) to slicing stage of vibratome. 
Use probe to spread glue to form a thin film.  
d. Place brain, ventral surface down onto the glue.  
e. Using a wide-mouth Pasteur pipette, apply a few drops of sucrose-ACSF to the brain to 
wash excess glue away from brain block.  
f. Place slicing stage in vibratome and flood slicing chamber with remaining ice-cold 
sucrose-ACSF. Take care to position the brain so that the entorhinal cortices are 
positioned closest to the vibratome blade. Place a carbogen line in the slicing chamber 
(Figure 3A-B).  
g. Move blade to brain surface, and then cut 400 μm thick horizontal slices containing the 
hippocampus (Figure 3C). 
 
Note: Slices tend to have better preservation of neuronal structure if they are cut slowly. Ideally 
cut slices at 0.05-0.1 mm/s forward blade movement, with a horizontal blade oscillation of 1-
1.5 mm.  
 
Note: A scalpel blade or a bent hypodermic needle can be used to trim the slices and separate 
the slices from each hemisphere before transferring into the holding chamber. 
 
Note: From a P28-35 mice it should be possible to obtain 8 slices (4 per hemisphere) containing 
the ventromedial portion of the hippocampus. For an equivalent age of rat, approximately 10-
12 slices of the ventromedial hippocampus can be obtained.  
 
h. Transfer slices to a submerged holding chamber filled with carbogenated sucrose-ACSF 
pre-warmed to 35°C and recover for 30 minutes (Figure 3D). 
 
i. Following recovery, transfer the holding chamber to the lab bench at 20 ± 2°C (room 
temperature) until the slices are required for recording. 
 
CRITICAL: Keep solutions bubbled with 95% O2/5% CO2 at all times to allow a sufficient partial 







Repeated whole cell patch-clamp recordings with dye filling 
 
Timing: 1 - 4 hours 
 
This step allows for assessment of cellular physiology of hippocampal neurons both under 
control conditions and following a prolonged depolarisation or osmotic controls within the same 
cell. Specific aspects of performing the whole cell patch clamp technique have been described 
previously (Booker et al., 2014, Neher and Sakmann, 1992). 
 
3. Transfer hippocampal slice to the recording chamber:  
a. Turn off inflow and outflow of recording-ACSF.  
b. Using a wide mouth Pasteur pipette transfer a brain slice from the holding chamber to 
the slice chamber.  
c. Take care to ensure that the dorsal surface is kept upwards.  
d. Place slice weight over slice, ensuring that anchor wires do not overlay the CA1 region 
of the hippocampus.  
e. Restart recording-ACSF flow. ACSF flow rate should be approx. 4-6 mL/min and should 
not be recirculated.  
 
Note: It may be helpful to modify the slice weight to give a large gap between anchor wires to 
prevent obfuscation of the CA1 region.  
 
4. Under low-magnification (10x objective) identify str. pyramidale of CA1 (Figure 4A).  
5. Exchange objective lens to high-magnification (40x objective) and identify healthy region 
of pyramidal cells (Figure 4B). 
a. Healthy CA1 pyramidal cells should have an ovoid cell body that is lightly contrasted 
with a halo of diffracted light around it. Any cells that are shriveled or shrunken are likely 
damaged or undergoing cell death.   
b. Typically identify a healthy looking cluster of cells that are located 50-100 µm below the 
slice surface.  
6. Fill a pre-prepared patch pipette with intracellular solution and place on electrode holder.  
 
Note: Ensure that Ag wire of headstage amplifier is suitably coated with AgCl prior to any 
recording. Any chips in AgCl coating will lead to undue capacitive currents and offset errors 
during recording.  
 
7. Apply positive pressure to patch pipette via pneumatic tube attached to electrode holder.  
8. Move patch pipette through recording-ACSF and “park” the pipette just above the slice so 
that the cell to be recorded is located within the proximal region of the pipette tip (Figure 
4B) 
9. Obtain a whole-cell patch-clamp recording from the first identified CA1 pyramidal cell, as 
previously described in detail (Booker et al., 2014) (Figure 4C and 4D). 
 
Critical: Recordings are excluded if resting membrane potential is more depolarized than -
50 mV at time of entering whole-cell configuration, or if access resistance is greater than 30 
MΩ or changes by more than 20% during the course of the recording. 
 






a. 30x -10 pA steps from the zero-current level (500 ms duration). This will assess 
resting membrane potential, input resistance and membrane time constant.  
b. From a membrane potential of -70 mV, 3x families of hyper-to depolarising 
current steps (-100 to +400 pA in 25 pA steps, 500 ms duration) 
11. Confirm spontaneous synaptic inputs by recording between 1 and 5 minutes of continuous 
recording at -70 mV voltage-clamp.  
 
Optional: Specific requirements of the recording may differ from this basic protocol. Depending 
on the hypothesis being tested, alternative whole-cell protocols may be required.  
 
 
12. Once the recording is complete, confirm dye filling under epifluorescent imaging (typically 
5-10 minutes of recording is sufficient to dye fill the somatodendritic regions) and perform 
an outside-out patch: 
a. Close IR-DIC light source and increase exposure time of digital camera (100-200 ms 
works well).  
b. Move filter turret to correct filter-set for fluorescent dye used.  
c. Move focus to identify filled cell (Figure 4D).   
d. Form outside-out patch by slowly retracting the patch electrode under visual guidance.  
e. When access resistance begins to increase, slowly increase holding potential towards 
~-40 mV. 
 
Note: in performing out-side out seals, access resistance is observed to smoothly increase 
from 5-30 MΩ to the 1-10 GΩ range. Increasing the holding potential, facilitates rupture of the 
retracted membrane.  
 
f. Continue retracting pipette until well clear of resealed cell.  
g. Confirm continued presence of filled cell both under IR-DIC and fluorescence.  
13. Repeat procedure for a further 2-4 cells.  
a. Make note of the order of which cells are recorded. This can be aided by drawing a map 
or taking images of the fluorescently labelled cells.   
14. Once all recordings are complete and viability of resealing confirmed, place slice into 
appropriate treatment:  
a. Stop inflow and outflow of recording ACSF 
b. Remove slice weight 
c. Using the wide mouth Pasteur pipette remove slice from the recording chamber and 
place in treatment chamber.  
d. Note time slice treatment was started.  
e. Rinse transfer pipette with distilled water.  
 
Note: To account for time since slicing affecting the recording conditions for individual slices, 
recorded slices should be treated with different KCl or NaCl in a counterbalanced manner – i.e. 
alternating treatment within day and rotating of which treatment is used first between days.   
 
Optional: This protocol is based on our recent study (Booker et al., 2020a) in which we 
employed prolonged depolarization of neurons by application of 15 mM KCl to examine cell 
excitability. Many other methods of modifying cell excitability could be employed (e.g. 4-






requirement is that the agent used is easily and rapidly washed out of the tissue to allow 
comparison of physiological states under identical conditions.   
 
15.  Repeat procedure for the remaining slices and alternate treatment conditions.  
 
Pause Point: If break is required, following treatment of slice a pause can be taken.  
 
16. Following treatment, remove slice from treatment chamber and return to recording 
chamber.  
a. Ensure that the same side of slice is positioned up, to allow direct access to dye 
filled cells.  
b. Place slice weight on slice, avoiding CA1 region of the slice. 
c. Allow 3-5 minutes for ACSF to fully wash out treatment ACSF.  
 
Note: If recirculation of ACSF is unavoidable, ensure that it is not recirculated while any 
residual treatment solution is washed through the perfusion tubing to prevent effected on cell 
excitability.  
 
17. Using fluorescence microscopy, identify the previously filled cells, comparing to the 
map/images taken previously (Figure 4E).  
 
18. Perform whole-cell patch-clamp recordings on dye filled cells, starting with first filled cell and 
moving through the selection that have survived treatment (Figure 4F).  
 
19. For all cells, once recording has been completed, reseal the patch of membrane with outside-
out patch formation as in Step 12.  
 
Note: For consistency, the faster that these recording can be performed the more likely they 
reflect the state of the slice immediately after treatment. We aim to re-record all cells within ~20 
minutes of slice returning to normal ACSF. This may dictate how many cells are filled in the first 
phase of recording and the number of recording protocols used. Using a very brief recording 
protocol, and experienced electrophysiologist can re-record 3-4 cells within this time frame.  
 
20. Once all filled cells have been recorded and resealed, slices should be fixed within minutes 
of last recording. Once removed from the perfusing ACSF, the slice should be fixed 
immediately (less than 1 minute).  
a. Start by turning off all inflow and outflow pumps.  
b. Remove the slice weight.  
c. Carefully extract the slice using the slice transfer pipette. 
d. Place the slice into a fixation vessel (e.g. a multi-well plate or bijou bottle) 
21. Fix slices using 4% PFA in 0.1M PB: 
a. Extract excess recording-ACSF using a Pasteur pipette. 
b. Apply 2-3 mL of fresh 4% PFA in PB to the slice 
c. Swirl or agitate the slice slightly to ensure that it is free-floating and not adhered 
to the wall of the vessel.  
d. Keep slices in 4% PFA at 20 ± 2°C (room temperature) for 1 hour 








CRITICAL: Longer fixation time results in over-fixation of tissue and can compromise the quality 
of antibody labelling (See Figure 5). 
 
CRITICAL: All tools and consumables used for fixation of tissue should be entirely separate 
from electrophysiology tools. The presence of PFA is highly deleterious to vitality of neurons 
and all steps should be taken to separate physiology and fixation areas, including separate 
bench space.  
 
Note: At this point, it can be helpful to transfer fixed slices to a multi-well plate for storage and 
future immunolabelling. Each experimental slice should occupy its own individual well and be 
labelled with a unique experimental identifier (i.e. date and slice number) 
 




Immunohistochemistry of fixed acute brain slices:   
 
Timing: 3 - 4 days 
 
This step allows for recovery of the recorded cells to assess their morphology and concomitant 
visualization and measurement of axon-initial segments (AIS) in the same slices (Figure 5A-
B). This process is highly reliable and allows for accurate detection of AIS structure, as well as 
measurement of somatodendritic structure. Inclusion of anti-NeuN primary antibodies labels 
neuronal somata and can help visualize the hippocampal formation. 
 
 
22. Wash slices thoroughly in PBS.  
a. Remove excess storage PBS from well with plastic Pasteur pipette 
b. Fill well containing slice with fresh PBS (approx. 3-5 mL)  
c. Repeat a further 2-3 times to fully remove any residual buffer and PFA. Washes should 
last 5 - 10 minutes per repetition. 
 
CRITICAL: Care should be taken to maintain the order of which slice is within which well of the 
multi-well plate.  
 
23. Block non-specific antigenicity in slices, to improve signal to noise of immunolabelling. 
a. Prepare blocking solution containing 10% normal goat serum (NGS), 0.3% Triton- X100 
(to allow membrane permeabilization and antibody penetration) and 0.05% NaN3 (to 
limit microbial growth), in PBS.  
b. Add 0.5 mL of blocking solution to each well of a 24-well plate labelled with the unique 
slice identifiers 
c. Transfer each slice to their according well with a soft, fine paintbrush 
 
Note: Care should be taken to not damage the slice. Slices are best lifted out of the well by 
sliding the brush under the slice and lifting out of the buffer in an upwards motion.  
 







24. Incubate slices with primary antibodies:  
a. Prepare fresh antibody dilution solution, containing: 5% NGS, 0.3% Triton-X100, 0.05% 
NaN3 all diluted in PBS. 
b. Add primary antibodies:  
Mouse anti-Ankyrin G (1µg/mL or 1:1000 of neat antisera) 
Rabbit anti-NeuN (1µg/mL or 1:1000 of neat antisera) 
 
Note: Antibodies should be stored according to the manufacturer’s guidelines. For most primary 
antibodies, we prepare aliquots of neat antisera (5-20 µL) and store at -20°C until used. 
Repeated freeze-thaw cycles of antibodies severely impair their antigenicity.  
 
c. Add 0.5 mL of prepared antibody solution to each well of a fresh, clean 24-well plate. 
d. Transfer slices to their according well with a paintbrush, rinsing the brush in clean PBS 
between slices.  
e. Cover the 24-well plate with lab film (i.e. Parafilm) to prevent evaporation of buffer.  
f. Place 24-well plate on orbital shaker in cool room or fridge. 
g. Incubate slices for at least 18 to 24 hours (overnight) at 4 °C 
 
Note: For thick slices, longer incubation can improve the penetration of antibodies deeper into 
the slice. As such, we often incubate for 2-3 days rather than just 1 overnight period. 
 
25. Wash slices thoroughly in PBS.  
a. Fill clean multi-well plates with PBS buffer.  
b. Transfer slice from primary antibody plate to PBS buffer using a fine paintbrush.  
c. Remove excess storage PBS from well with plastic Pasteur pipette 
d. Fill well containing slice with fresh PBS (approx. 3-5 mL)  
e. Repeat a further 2-3 times to fully remove any residual buffer and PFA. Washes should 
last 5 - 10 minutes per repetition. 
 
CRITICAL: Care should be taken to maintain the order of which slice is within which wellplate 
well.  
 
26. Apply secondary antibodies:  
a. Prepare secondary antibody buffer: 3% NGS, 0.3% Triton-X100, 0.05% NaN3 in PBS. 
b. Add secondary antibodies:  
Goat anti-Mouse AlexaFluor 488 (4 µg/mL or 1:500 of neat sera) 
Goat anti-Rabbit AlexaFluor 633 (4 µg/mL or 1:500 of neat sera) 
Steptavidin-Alexafluor 568 conjugate (4 µg/mL or 1:500 of neat sera) 
 
Note: Use streptavidin conjugated fluorophore with same spectral properties as the AlexaFluor 
dye used to fill neurons during the recording. (i.e. Streptavidin-AlexaFluor568 conjugate is used 
with Alexa-568 hydrazide dye) to avoid potential contamination of signals with residual 
fluorescence from filling. 
 
Note: Secondary antibody combinations can be tailored to your specific confocal microscope 
configuration. Given the relative size and labelling strength of AnkyrinG, shorter wavelengths 
are optimal. As NeuN is less important for reconstruction of neurons, we often use this in the 







c. Add 0.5 mL of prepared antibody solution to each well of a fresh, clean 24-well plate. 
d. Transfer slices to their according well with a paintbrush, rinsing the brush in clean PBS 
between slices.  
e. Cover the 24-well plate with lab film (i.e. Parafilm) to prevent evaporation of buffer.  
f. Place 24-well plate on orbital shaker in cool room or fridge. 
g. Incubate for 18 to 24 hours at 4 °C 
 
27. Wash slices thoroughly in PBS.  
a. Fill clean multi-well plates with PBS buffer.  
b. Transfer slice from primary antibody plate to PBS buffer using a fine paintbrush.  
c. Remove excess storage PBS from well with plastic Pasteur pipette 
d. Fill well containing slice with fresh PBS (approx. 3-5 mL)  
e. Repeat a further 2-3 times to fully remove any residual buffer and PFA. Washes should 
last 5 - 10 minutes per repetition. 
 
28. Desalt slices:  
a. Fill clean multi-well plates with PB buffer (3-5 mL/well).  
b. Transfer slice from PBS buffer to PB buffer using a fine paintbrush.  
c. Rinse paintbrush between transfers, 
d. Stir on orbital shaker for 10-15 minutes 
e. Remove excess storage PB from well with plastic Pasteur pipette 
f. Fill well containing slice with fresh PB (approx. 3-5 mL) 
g. Stir on orbital shaker for 1 hour.  
 
29. Mount slices on glass slides 
a. Label glass microscope slide with unique slice identifier and antibodies used.  
b. Remove slice from PB multi-well plate using paintbush.  
c. Blot excess PB from slice by touching brush to a piece of tissue, then gently lay slice on 
slide.  
 
Critical: When mounting slices on glass slide, maintain the side of the slice with the recorded 
cell facing up. The correct side of the slice can be identified by the marks left by the threads of 
the slice weight used during electrophysiological recordings. Alternatively, a note of the slice 
orientation can be made during recording. 
 
d. Blot any residual PB from slice, using a cut wedge of tissue or filter paper.  
e. Place sufficient fluorescent mounting medium (e.g. Vectashield Hardset mounting 
medium) on slice (2-3 drops for 22 x 22 mm coverslip).  
f. Lay coverslip over slice.  
 
Note: To prevent bubbles forming on slice surface, it is advised to lay coverslip from one edge, 
then slowly allow remainder of coverslip to fall into place.  
 
g. Place mounted slides in a cool, dark place for 1-2 hours to allow hard-set mounting 
medium to harden.  
h. Seal coverslips with nail polish around the edge. 







Pause Point: Slides can be kept at 4 ºC for a few days before imaging, but it’s recommended 
that images are taken within the first 2 weeks post-immunohistochemistry to avoid deterioration 
of labelling quality with time. 
 
Confocal imaging of the AIS and filled neurons:  
 
Timing: 20 – 60 minutes per slice.  
 
This step allows for recovery of morphology of the recorded cell and concomitant visualization 
of AISs in the slice.  
 
30. Once slides have fully equilibrated with the mounting medium (~1 day) the refractive index 
of the fixed slices will have reduced to facilitate imaging.  
31. Place slices at 20 ± 2°C (room temperature) ~15 minutes prior to imaging to allow warming 
to ambient temperature.  
32. Acquire high-resolution Z-stacks including CA1: 
a. Place slide in confocal microscope 
b. Under epifluorescent imaging and a low magnification objective (x10 or x20), identify 
the CA1 region by the presence of streptavidin labelling of the filled neurons.  
c. Set appropriate light path for confocal imaging and excitation laser wavelength 
according to the fluorophores used. 
d. Apply a small amount (1-2 drops) of immersion medium and exchange objective lens to 
a 63x oil immersion objective. 
e. Use the volume imaging function of your confocal microscope to acquire high resolution 
Z-stacks through CA1 (1024x1024 xy resolution, pixel size: 0.14 µm, 1 µm z steps). 
 
Note: Due to limited antibody penetration deeper in the slice, fluorescent labelling intensity is 
very bright in the slice surface and fainter deeper in the tissue, scan through optical sections at 
different depths to set the most appropriate laser intensity/detector gain that allows for high 
signal/noise for as much of the tissue as possible (Figure 6A). For image acquisition, we used 
either an Axiovert LSM 510 or LSM800 laser scanning confocal microscopes (both Zeiss, 
Germany), which were obtained with 63x (1.4 NA) oil or silicone immersion objective lenses.  
 
Optional: This protocol is based on our recent study (Booker et al., 2020a) in which we 
assessed the effect of prolonged depolarization with 15 mM KCl on AIS length. Nonetheless 
the presence of biocytin filled neurons and the quality of AnkG labelling in these sections also 
allow for a deeper morphological analysis of the AIS and reconstruction of CA1 PC morphology. 
In that case imaging conditions must be adapted for each specific purpose as described in 
steps 33 and 34. 
 
33. For 3-dimensional reconstruction of neurons, including the AIS, start by obtaining high 
resolution images, to allow deconvolution of images and accurate surface rendering.  
 
Note: We use the Huygens deconvolution software to deconvolve images. Other software is 
available, however images should be collected to Nyquist sample the 3-dimensional volume. 
 






b. Under low magnification (i.e. 10x or 20x Objective lens) identify the CA1 region of the 
slice. The specific microscope settings depend on the quality of the labelling and the 
choice of fluorescent markers used. 
c. Apply a small amount (1-2 drops) of immersion medium and exchange objective lens.  
 
Note: Use the appropriate immersion medium for your objective lens, according to 
manufacturer’s guidelines.  
 
d. Under high magnification identify the str. pyramidale layer of CA1. 
e. Using the volume imaging function of your confocal microscope set the top (slice 
surface) and bottom (end of intense labelling) extents of your 3-dimensional volume.  
f. Set the z-step size to 0.13 µm. 
g. Establish optimal laser power and detector gain settings for start and end of volume.  
h. If microscope is capable, set these values to automatically modulate over the slice depth  
i. Acquire image stack at 2048 x 2048 resolution under 2x zoom, which gives a pixel width 
of 0.04 µm (Figure 7A). 
j. During acquisition modulate the detector gain and laser power to generate consistent 
image quality through volume.  
 
Note: The images presented here were collected using a LSM800 confocal microscope (Zeiss, 
Germany). The specific microscope settings were 1.2% of maximum power from a continuous 
spectrum laser and 599V gain on the PMT detectors.  
 
CRITICAL: For appropriate volume rendering of AIS structure under diffraction limited light 
microscopy a voxel with vertices of 0.04 x 0.04 x 0.13 µm is optimal.  
 
34. Full neuron morphology can be examined and reconstructed using a similar method, 
albeit with larger step sizes (0.5 -1 µm) and no zoom, as described previously (Booker et al., 
2014). 
 
Note:  Due to the axial point-spread function produced by imaging with longer wave-length 





The protocol described here allows for multiple recordings from identified CA1 pyramidal cells 
both before and after a prolonged treatment with a depolarizing stimulus and the appropriate 
osmotic control (i.e. 15 mM KCl and 15 mM NaCl, respectively) as we have recently employed 
(Booker et al., 2020a). This approach allows for a highly correlated physiological 
characterization of the effects of long-term treatment, overcoming cell-to-cell or slice-to-slice 
variability that is inherent to recording from different cells for each treatment. Following 
recording, the brief fixation and immunohistochemistry protocol used then allows for 
visualization of recorded neurons and the AIS in the same slices, thus allowing for correlated 
structural analysis of the same tissue that has undergone this depolarizing treatment. 







From whole-cell patch-clamp recordings it is possible to obtain detailed electrophysiological 
measurements of cell excitability, such as active firing properties, action potential kinetics, and 
passive membrane properties (Figure 8). By incorporating a fluorescent dye into the 
intracellular recording solution, this allows for identification of the recorded neurons following 
treatment of the slice outside of the recording chamber,and facilitates repeated whole-cell 
recording of the same cells (Figure 4). Based on this protocol and our recent study (Booker et 
al., 2020a), these repeated patch-clamp recordings minimally affect cellular physiology as 
indicated by minimal change in excitability when treated with the physiologically inert 15 mM 
NaCl osmotic control (Table 1, Figure 8A) and is useful in identifying physiological changes 
following 15 mM KCl treatment (Figure 8B).  
 
 
Table 1: Summary of intrinsic physiological properties of wild-type CA1 pyramidal cells 
recorded before and after 15 mM NaCl osmotic control. Data is shown as the mean ± SEM 
from 10 CA1 pyramidal cells from 5 mice. Statistics are reported from Student’s 2-tailed paired 
t-tests. These data have been re-analyzed from recordings reported previously (Booker et al., 
2020a). 
 
 Recording 1 Recording 2 p-value 
Resting membrane potential (mV) -61.8 ± 3.4 -60.5 ± 2.1 0.7169 
Input resistance (MΩ) 168 ± 20 167 ± 20 0.9463 
Membrane time-constant (ms) 27.2 ± 3.4 25.9 ± 2.0 0.6906 
Rheobase (pA) 146 ± 17 149 ± 20 0.8696 
Voltage threshold (mV) -40.9 ± 1.7 -40.2 ± 1.4 0.7379 
Action potential amplitude (mV) 119 ± 2 113 ± 3 0.1538 
Half-height duration (ms) 1.00 ± 0.05 1.07 ± 0.07 0.2810 
Maximum action-potential frequency (Hz) 36.5 ± 3.4 38.3 ± 4.2 0.6801 
 
 
Provided that good slice quality is maintained (Figure 4B), then it is possible to record multiple 
cells per slices before and after treatment. However, the technical ability of the experimenter 
will determine the number of cells that can be recorded in a given slice within the shortest 
possible time frame. An important consideration is to compare the values obtained in starting 
recordings from those performed without the time constraints of repeated whole-cell patch-
clamp experiments (i.e. under true control conditions). It is critical that either vehicle or osmotic 
controls are included in any such experiment, to discount the effect of repeated whole-cell 
recording on the specific physiological parameter being measured.  
 
Following recordings, our protocol provides a method to perform high resolution imaging of the 
AIS from slices that have undergone depolarizing treatment and recording. If labelling has been 
successful it is expected that highly intense labelling for AnkyrinG is observed in the proximal 
portion of stratum oriens in CA1 (Figures 5, 6, 7). When viewed under high-power magnification 
this labelling is due to the presence of a high number of immunolabelled AIS that often emerge 
from the base of the CA1 pyramidal cell somata and extend ~20-40 µm into stratum oriens. It 
is expected that the AIS begins as a wide structure (2-3 µm) and tapers to a fine ending 
(<0.5 µm), forming a conical structure, spines are sometimes observed emanating from the 






by weak NeuN labelling that fills the proximal dendritic cytoplasm. Based on this quality of 
labelling, it is possible to reconstruct the AIS for analysis of its length, surface area, width, and 
starting location relative to the soma in 3-dimensions (Figure 7).  
 
 
Quantification and Statistical Analysis  
 
Electrophysiology analysis: 
Analysis of electrophysiological data was performed using Stimfit (Guzman et al 2014). 
 
1. Passive membrane properties were measured from the voltage response to a small 
hyperpolarizing current step (-10 pA, Figure 8A and 8C): 
a. Membrane time constant was determined by fitting of a monoexponential curve 
to the initial voltage response using the “fit function to data” tool. 
b. Peak cursors were set to the final 100 ms of the current step allowing to 
determine the steady state voltage response to the current step and 
subsequently calculate input resistance according to Ohm’s Law.  
 
2. AP kinetics and AP discharge were quantified from the voltage response to a family of 
depolarizing current steps from -100 to +400 pA in 25 pA increments. 
a. AP kinetics were analysed for the first AP elicited and measured from threshold set 
as 20mV.ms-1: 
b. Once peak cursors are set to flank the desired AP (Figure 8D), the batch analysis 
tool can be used to measure kinetic properties including half-height duration, AP 
threshold and AP rise and decay rates (Figure 8E). 
c. AP discharge was quantified by selecting all traces and using the “batch analysis” 
tool to count the number of threshold crossings for each current injection step. 
AIS length analysis: 
3. Import microscope image files to FIJI (Image J). 
4. AISs can be reliably measured by scrolling through the 3D Z-stack and manually tracing 
each AIS from the proximal to distal end. Tracing can be achieved using the segmented 
line tool: double click at the proximal end of the AIS to initiate tracing, use single clicks 
to mark points throughout the length of the AIS and allow for changes in direction, 
double click again at the distal end of the AIS to terminate the region of interest (ROI). 
Note: Avoid tracing AISs that are cut at the surface of the slice or at the edges of the field 
of the image (Figure 6B-C). 
5. Once an AIS has been traced it can be added to the ROI manager by pressing ‘T’ on 
the keyboard. 
6. Repeat steps 4 and 5 until a suitable number of AISs have been traced (in our study we 
analysed 50 per image and 2 images per treatment condition for each mouse). This 
creates a list of ROIs correspondent to the traced AISs. 






Note: ROIs and respective measurements can be saved as .zip and .csv files respectively for 
future reference. 
Note: Alternative semi-automated methods for AIS measurement have been employed by 
others (Grubb and Burrone, 2010, Gutzmann et al., 2014, Pan-Vazquez et al., 2020). Whilst 
these provide a time efficient alternative to manual tracing of individual AISs their accuracy 
should be validated against manual measurements for your own labelling and imaging 
conditions. 
 
Three-dimensional reconstruction of AIS  
The AIS was reconstructed in 3 dimensions to allow for surface rendering, similar to previous 
reports (Favuzzi et al., 2019). 
8. Deconvolve images using Huygens Essential software package. 
a.  Import microscope images (including header file information) into Huygens 
Essential software (Figure 7A) 
b. Set optical settings according to preparation of slides, i.e. refractory index of 
embedding medium (1.46 for Vectashield Hardset mounting medium).  
c. Set deconvolution settings:  
i. automatic estimation,  
ii. 1 µm area radius,  
iii. 100 maximum iterations,  
iv. 20 signal to noise ratio 
v. 0.1 quality threshold.  
vi. All other values are automatically loaded from image metadata. 
 
Note: These settings are optimized for our imaging conditions and optimization should be 
performed for each sample prior to reconstruction (Figure 7B).  
 
9. Reconstruct AIS volumes 
a. Import deconvolved images into Imaris analysis software 
b. Render surfaces using the Surfaces tool  
i. 0.3 surfaces detail  
ii. 1 µm background subtraction.  
iii. Quality threshold was automatically set.  
c. The Surfaces Split function was applied to split the reconstruction into individual 
AIS surface objects.  








Statistical analysis of electrophysiology data 
Given the paired nature of experiments from control and treatment conditions, paired statistical 
analysis should be performed to take into account the power obtained by performing repeated 
patch-clamp recordings.  
Power analysis to calculate the required sample sizes to detect a difference in rheobase 
between control and treated recordings revealed a paired T-test would require a sample size 
of 16 cells to detect a difference between groups, whilst an unpaired T test would require a 
sample size of 44 cells per group. Power calculation was performed assuming 95% power, 95% 
confidence interval and based on the standard deviation and mean rheobase values from 
control and KCl treated slices in WT mice published in our previous study (control: 159 ± 54 pA, 
KCl: 221 ± 99 pA, mean ± SD, Booker et al 2020a).  
Nonetheless, to avoid potential pseudoreplication effects when multiple recordings per animal 
are performed, mixed effects modelling is the most appropriate method to test for statistical 
differences (LMER function, R-Studio). 
Statistical analysis of AIS length data 
First, to assess AIS length distributions across treatment conditions we performed a 
Kolmogorov-Smirnov test, based on the average cumulative distribution. This was performed 
on cumulative distributions in which the AIS lengths from each animal were binned (e.g. into 
bins of 0.5 – 1 µm, dependent on variability). Once binned, each histogram was averaged 
between animals across bins, to allow direct comparison (Booker et al., 2020a). 
For statistical comparison of AIS length under control and treatment conditions an average of 
AIS length should be obtained for each condition and each animal and a parametric or non-
parametric test performed as appropriate. Ideally, a linear mixed effect model should be applied 
to compare AIS length across treatments, with “Treatment” as a fixed effect and “animal” and 




There are a number of technical and conceptual limitations to the current protocol. First, there 
is an inherent risk of damage to the slice each time it is handled. This can be overcome by 
using a wide-mouth transfer pipette and ensuring that all pumps are turned off before 
introducing the slice to the chamber  
Second, slice health deteriorates over time, thus limiting the length of treatment that can be 
tested. Adaptation of this protocol to organotypic slices might allow for longer treatment 
windows.  
Moreover, it is not always possible to label the AIS of the recorded cell, depending how deep 
in the tissue the cell was located. Ressectioning of the slices into thinner sections could 
circumvent this limitation but it might compromise recovery of cell morphology. 
Another limitation is the low data throughput. Multiple cells per slice need to be recorded pre-







Finally, this approach may not be the most efficient for shorter pharmacological or plasticity 
treatments (<1 hour), in which case continual recording may be more appropriate. This should 











Recordings from CA1 pyramidal cells are not reliably of high quality and cells do not 
form reliable seals (steps 9-10).  
 
Potential Solution:  
 
The most likely cause is poor slice quality. To remedy this, decrease the time it takes to remove 
the brain and place in ice cold sucrose-ACSF and take greater care when handling the brain 
during placement in slicing chamber. Healthy slices should display multiple ovoid neurons 
located near to the slice surface (Figure 4B). 
 
Also, double check if the solution composition is correct. Check the pH and osmolarity of 
solutions used for recording, as equilibrated with carbogen and warmed at the time of recording. 
Ideal pH should be 7.3 to 7.4 when measured at 30 °C and osmolarity should be 290-




Following 3 hours of depolarization or osmotic control, no fluorescently labelled cells 
are present in the slice (step 17).  
 
Potential Solutions:  
Check the following possibilities: 
 
Is the slice in the same orientation as it was during the first recording session? Try turning the 
slice over and check for labelled cells. 
 
Is a reliable Gigaohm seal formed following first recording? Confirm the presence of the 
gigaohm seal by monitoring electrode retraction in the seal-test mode of the amplifier. Under 
IR-DIC confirm that the cell is maintained in the slice and that the nucleus has not been 
accidentally withdrawn as well (step 12). 
 
Are the cells sufficiently deep within the slice, to prevent damage at the surface, from being 
stored for an extended period? Try to record from neurons that are embedded deeper within 
the slice.  
 
Slice quality is not sufficient to maintain slices at 35 °C for 3 hours. See Problem 1 for 
suggestions of improving slice quality.  
 
Record from more cells. Not every neuron survives 3 hours of treatment, despite best efforts. 







Is the solution composition correct? Check the pH and osmolarity of solutions used for 
recording, as equilibrated with carbogen and warmed at the time of recording. Ideal pH should 




No labelling for AnkyrinG is present in the slice (step 32; Figure 5C).  
 
Potential Solution:  
 
Are the confocal microscope imaging settings correct for the wavelengths required for 
excitation/emission of the used secondary antibodies? Does the confocal microscope detect 
the streptavidin labelling of the filled neurons? Confirm that the microscope is functioning 
correctly by imaging a known calibration standard (e.g. dye beads) or test samples in another 





Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Sam A. Booker, sbooker@ed.ac.uk. 
 
Materials Availability 
All materials used in this protocol are commercially available.  
 
Data and Code Availability 
This study did not generate/analyse datasets/code. 
Acknowledgments  
 
The authors would like to thank our funders, the Simons Initiative for the Developing Brain 
(SFARI Grant: 529085) for facilitating our research. Second, we wish to thank Professors Peter 
C Kind and David JA Wyllie and the members of their labs for help with developing these 
methods. Finally, to the IMPACT imaging facility at the University of Edinburgh for technical 




LSO – devised the protocol, performed experiments, and wrote the manuscript. SAB – devised 
the protocol, performed experiments, and wrote the manuscript. AS - performed experiments 







Declaration of Interests 









BOOKER, S. A. 2020b. Preparing Acute Brain Slices from the Dorsal Pole of the 
Hippocampus from Adult Rodents. Journal of visualized experiments: JoVE. 
BOOKER, S. A., CAMPBELL, G. R., MYSIAK, K. S., BROPHY, P. J., KIND, P. C., MAHAD, 
D. J. & WYLLIE, D. J. 2017. Loss of protohaem IX farnesyltransferase in mature dentate 
granule cells impairs short‐term facilitation at mossy fibre to CA3 pyramidal cell synapses. 
The Journal of Physiology, 595, 2147-2160. 
BOOKER, S. A., DE OLIVEIRA, L. S., ANSTEY, N. J., KOZIC, Z., DANDO, O. R., JACKSON, 
A. D., BAXTER, P. S., ISOM, L. L., SHERMAN, D. L. & HARDINGHAM, G. E. 2020a. Input-
output relationship of ca1 pyramidal neurons reveals intact homeostatic mechanisms in a 
mouse model of fragile x syndrome. Cell reports, 32, 107988. 
BOOKER, S. A., SONG, J. & VIDA, I. 2014. Whole-cell patch-clamp recordings from 
morphologically-and neurochemically-identified hippocampal interneurons. JoVE (Journal of 
Visualized Experiments), e51706. 
FAVUZZI, E., DEOGRACIAS, R., MARQUES-SMITH, A., MAESO, P., JEZEQUEL, J., 
EXPOSITO-ALONSO, D., BALIA, M., KROON, T., HINOJOSA, A. J. & MARAVER, E. F. 
2019. Distinct molecular programs regulate synapse specificity in cortical inhibitory circuits. 
Science, 363, 413-417. 
GRUBB, M. S. & BURRONE, J. 2010. Activity-dependent relocation of the axon initial 
segment fine-tunes neuronal excitability. Nature, 465, 1070-1074. 
GUTZMANN, A., ERGÜL, N., GROSSMANN, R., SCHULTZ, C., WAHLE, P. & 
ENGELHARDT, M. 2014. A period of structural plasticity at the axon initial segment in 
developing visual cortex. Frontiers in neuroanatomy, 8, 11. 
GUZMAN, S. J., SCHLÖGL, A. & SCHMIDT-HIEBER, C. 2014. Stimfit: quantifying 
electrophysiological data with Python. Frontiers in neuroinformatics, 8, 16. 
NEHER, E. & SAKMANN, B. 1992. The patch clamp technique. Scientific American, 266, 44-
51. 
PAN-VAZQUEZ, A., WEFELMEYER, W., SABATER, V. G., NEVES, G. & BURRONE, J. 
2020. Activity-dependent plasticity of axo-axonic synapses at the axon initial segment. 
Neuron. 
SCHNEIDER, C. A., RASBAND, W. S. & ELICEIRI, K. W. 2012. NIH Image to ImageJ: 25 
years of image analysis. Nature methods, 9, 671-675. 







THOME, C., KELLY, T., YANEZ, A., SCHULTZ, C., ENGELHARDT, M., CAMBRIDGE, S. B., 
BOTH, M., DRAGUHN, A., BECK, H. & EGOROV, A. V. 2014. Axon-carrying dendrites 




Figure 1: Assembly of a submerged slice holding chamber. A material necessary to build 
holding chamber (in order: alcohol burner, beaker, nylon mesh, 50 mL syringe, 20 mL syringe, 
superglue, scalpel). B Plastic inserts cut to form 2 compartments, one to hold the slices and 
another to place carbogen bubbler. C Nylon mesh stretched over smaller insert. D Finalized 
holding compartment. E Top view of finalized chamber with 2 compartments. F Side view of 
finalized chamber. 
 
Figure 2: Preparation of tools and chambers for acute brain slicing and storage/treatment of 
slices. A preparation of the vibratome chamber. B tools and equipment for the dissection of the 
brain and slicing of the hippocampus. 
 
Figure 3: Obtaining acute hippocampal slices. A Brain positioned on the vibratome stage. B  
vibratome chamber filled with carbogenated sucrose-ACSF. C Cutting horizontal slices 
containing the hippocampus. D Trimmed slices in the holding chamber. 
 
Figure 4: Placement of slice in chamber, recording and dye filling of CA1 pyramidal cells. A 
low power overview of the hippocampus under infra-red differential inference contrast (IR-DIC) 
microscopy, with recording site of B indicated (black box). Hippocampal subregions (white text), 
layers (black text), and the hippocampal fissure (dashed grey line) are indicated for reference. 
Scale bar: 200 µm. B high power (40x) IR-DIC image of a CA1 pyramidal cell with a patch-
pipette placed on the cell body. Scale bar: 20 µm. C epifluorescent image of the same neuron, 
before breaking in to whole-cell configuration. Note the absence of labelling in the cell body. 
Scale bar: 20 µm. D the same cell, but now in whole-cell configuration and having had filled for 
5 minutes. Scale bar: 20 µm. E fluorescent identification of the same cell after 3 hours 
incubation in 15 mM KCl. Scale bar: 20 µm. F whole-cell patch-clamp recording from the same 
cell under IR-DIC optics. Scale bar: 20 µm. 
 
Figure 5: Immunolabelling for the AIS from acute slices. A AnkyrinG immunolabelling (AnkG, 
green pseudocolour) shown in comparison to NeuN labelling (blue pseudocolour) allows the 
visualization of AISs in a field of view including CA1 of the hippocampus. Scale bar: 20 µm B 
higher magnification view of a single AIS. Scale bar: 10 µm C Poor quality AnkyrinG labelling 
in over-fixed tissue. Scale bar: 20 µm. D Visualisation and measurement of the AIS (AnkyrinG, 
green, top) in a biocytin labelled neuron (Bioc, greyscale, middle) and merged (lower). Scale 
bar: 20 µm. 
 
Figure 6: Depth profile of AnkyrinG and measurement of AIS length. A multiple single plane 
images of AnkyrinG (AnkG, green) immunolabelling through the Z-plane (distance from the slice 
surface indicated in µm). Scale bar: 20 µm. A (right) the orthogonal (zy) view of AnkG labelling 
in the zy axis. A’ overlay of AnkyrinG labeling with measured AIS profiles (white). B a single 
AIS followed through its z-plane from start to end (white triangles) suitable for length 
measurement. Scale bar: 10 µm. B’ the same AIS, but overlain with its segmented and 






start (white triangle) to the surface of the slice, where it is prematurely cut (white asterisk) and 
thus not suitable for length measurement. C’ Z projection of the AIS represented in C. Scale 
bar: 10 µm.  
 
Figure 7: Imaging of AnkyrinG immunolabelling for deconvolution and 3-dimensional 
reconstruction. A a flattened z-stack of high magnification and resolution images of AnkyringG 
(AnkG, green pseudocolour) in the CA1 pyramidal layer before deconvolution. DAPI is shown 
for comparison. Scale bar: 10 µm A’ a blow up image of an example AIS from A. Scale bar: 
10 µm. B flattened z-stack of the same image series following deconvolution. B’ the same 
example AIS, but following deconvolution. Note the sharper edges of the morphology and 
clearer association of AnkyrinG to the plasma membrane. C 3-dimensional reconstruction and 
rendering of the same AIS following deconvolution. Note the spine located on the AIS 
(arrowhead). Scale bar: 10 µm. 
 
Figure 8: Example recordings from before and after 15 mM KCl depolarization or 15 mM NaCl 
osmotic controls and analysis criteria. A (top) whole-cell patch-clamp recording from a CA1 
PC, and the resulting voltage measured in response to depolarizing stimuli (25 pA steps, 500 
ms), the 400 pA maximum firing step and the rheobase current trace is shown (grey). Traces 
are shown for control (i.e. first recording) and after 3 hours treatment with 15 mM NaCl (i.e. 
second recording). A (bottom) the response of this cell to a small -10 pA, 500 ms current step. 
The control trace is underlain in the 15 mM NaCl trace (grey). B a recording from a CA1 PC but 
before and after 15 mM KCl, according to the same scheme as A. C example trace of -10 pA 
step with fitting of monoexponential curve (gray overlain) to determine membrane time constant 
and setting of baseline (green dashed lines) and peak cursors to measure peak voltage 
response (ΔVm) to determine input resistance. D Rheobase current step with peak cursors (red 
dashed lines) flanking the first AP fired used to analyse action potential kinetics. E 
representation of action potential kinetic measurements: red horizontal line - half height 
duration; vertical green arrow – action potential amplitude from threshold; ascending and 
descending blue arrows – action potential maximum rise and decay rates respectively. 
 
 
 
 
